1. Home
  2. TTNP vs KXIN Comparison

TTNP vs KXIN Comparison

Compare TTNP & KXIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TTNP
  • KXIN
  • Stock Information
  • Founded
  • TTNP 1991
  • KXIN 2015
  • Country
  • TTNP United States
  • KXIN China
  • Employees
  • TTNP N/A
  • KXIN N/A
  • Industry
  • TTNP Biotechnology: Biological Products (No Diagnostic Substances)
  • KXIN Retail-Auto Dealers and Gas Stations
  • Sector
  • TTNP Health Care
  • KXIN Consumer Discretionary
  • Exchange
  • TTNP Nasdaq
  • KXIN Nasdaq
  • Market Cap
  • TTNP 3.4M
  • KXIN 2.8M
  • IPO Year
  • TTNP 1996
  • KXIN N/A
  • Fundamental
  • Price
  • TTNP $4.00
  • KXIN $0.92
  • Analyst Decision
  • TTNP
  • KXIN
  • Analyst Count
  • TTNP 0
  • KXIN 0
  • Target Price
  • TTNP N/A
  • KXIN N/A
  • AVG Volume (30 Days)
  • TTNP 33.6K
  • KXIN 92.7K
  • Earning Date
  • TTNP 05-14-2025
  • KXIN 01-01-0001
  • Dividend Yield
  • TTNP N/A
  • KXIN N/A
  • EPS Growth
  • TTNP N/A
  • KXIN N/A
  • EPS
  • TTNP N/A
  • KXIN N/A
  • Revenue
  • TTNP N/A
  • KXIN N/A
  • Revenue This Year
  • TTNP N/A
  • KXIN N/A
  • Revenue Next Year
  • TTNP N/A
  • KXIN N/A
  • P/E Ratio
  • TTNP N/A
  • KXIN N/A
  • Revenue Growth
  • TTNP N/A
  • KXIN N/A
  • 52 Week Low
  • TTNP $3.03
  • KXIN $0.90
  • 52 Week High
  • TTNP $14.80
  • KXIN $29.52
  • Technical
  • Relative Strength Index (RSI)
  • TTNP 55.27
  • KXIN 25.41
  • Support Level
  • TTNP $3.48
  • KXIN $0.90
  • Resistance Level
  • TTNP $4.47
  • KXIN $1.04
  • Average True Range (ATR)
  • TTNP 0.35
  • KXIN 0.06
  • MACD
  • TTNP 0.01
  • KXIN 0.01
  • Stochastic Oscillator
  • TTNP 56.07
  • KXIN 8.39

About TTNP Titan Pharmaceuticals Inc.

Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.

About KXIN Kaixin Auto Holdings

Kaixin Holdings is an auto retail platform for luxury used cars and imported new cars. The company is actively engaged in the research and development, design, manufacturing, and sales of electric vehicles and promotes the innovation of next-generation autonomous driving and artificial intelligence technologies. The company primarily generates revenues from sales of used cars, as well as fees obtained from its role as a channel partner for third-party auto financing and other value-added service providers.

Share on Social Networks: